1. Home
  2. ELVN vs TCBK Comparison

ELVN vs TCBK Comparison

Compare ELVN & TCBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • TCBK
  • Stock Information
  • Founded
  • ELVN 2016
  • TCBK 1975
  • Country
  • ELVN United States
  • TCBK United States
  • Employees
  • ELVN N/A
  • TCBK N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • TCBK Major Banks
  • Sector
  • ELVN Health Care
  • TCBK Finance
  • Exchange
  • ELVN Nasdaq
  • TCBK Nasdaq
  • Market Cap
  • ELVN 1.2B
  • TCBK 1.3B
  • IPO Year
  • ELVN 2020
  • TCBK N/A
  • Fundamental
  • Price
  • ELVN $20.22
  • TCBK $44.21
  • Analyst Decision
  • ELVN Strong Buy
  • TCBK Buy
  • Analyst Count
  • ELVN 5
  • TCBK 5
  • Target Price
  • ELVN $41.20
  • TCBK $47.60
  • AVG Volume (30 Days)
  • ELVN 335.0K
  • TCBK 84.5K
  • Earning Date
  • ELVN 08-13-2025
  • TCBK 07-24-2025
  • Dividend Yield
  • ELVN N/A
  • TCBK 3.10%
  • EPS Growth
  • ELVN N/A
  • TCBK N/A
  • EPS
  • ELVN N/A
  • TCBK 3.39
  • Revenue
  • ELVN N/A
  • TCBK $391,277,000.00
  • Revenue This Year
  • ELVN N/A
  • TCBK $9.45
  • Revenue Next Year
  • ELVN N/A
  • TCBK $5.81
  • P/E Ratio
  • ELVN N/A
  • TCBK $12.56
  • Revenue Growth
  • ELVN N/A
  • TCBK 0.78
  • 52 Week Low
  • ELVN $13.30
  • TCBK $35.20
  • 52 Week High
  • ELVN $30.03
  • TCBK $51.06
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.43
  • TCBK 56.64
  • Support Level
  • ELVN $19.30
  • TCBK $42.46
  • Resistance Level
  • ELVN $20.28
  • TCBK $43.26
  • Average True Range (ATR)
  • ELVN 1.19
  • TCBK 0.83
  • MACD
  • ELVN 0.15
  • TCBK 0.07
  • Stochastic Oscillator
  • ELVN 59.11
  • TCBK 72.70

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

Share on Social Networks: